Metastatic Breast Cancer

Overview

Journal Aust Fam Physician

Specialty Public Health

Date 2006 May 9

PMID 16680209

Citations 9

Authors

Amanda Stevanovic

Philip Lee

Nicholas Wilcken

Affiliations

Soon will be listed here.

Abstract

This fourteenth article in our series on breast disease gives an overview of what to look for in the patient with a past history of early breast cancer and how to assess and support the patient with metastatic breast cancer in the general practice setting. Information about the latest medical oncology treatments, including new chemotherapies and targeted 'biological' therapies is provided.

Citing Articles

Notch signaling in female cancers: a multifaceted node to overcome drug resistance.

Giuli M, Mancusi A, Giuliani E, Screpanti I, Checquolo S Cancer Drug Resist. 2022; 4(4):805-836.

PMID: 35582386 PMC: 8992449. DOI: 10.20517/cdr.2021.53.

Combination of intensity modulated radiotherapy followed treatment with p38 MAPK activation inhibitor inhibits the proliferation of MCF-7 breast cancer cells.

Zhao J, Cheng G, Liu J Saudi J Biol Sci. 2018; 25(1):10-14.

PMID: 29379349 PMC: 5775077. DOI: 10.1016/j.sjbs.2017.01.061.

Awareness and current knowledge of breast cancer.

Akram M, Iqbal M, Daniyal M, Khan A Biol Res. 2017; 50(1):33.

PMID: 28969709 PMC: 5625777. DOI: 10.1186/s40659-017-0140-9.

Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases.

Flamini M, Uzair I, Pennacchio G, Neira F, Mondaca J, Cuello-Carrion F Horm Cancer. 2017; 8(1):16-27.

PMID: 28050799 PMC: 10355986. DOI: 10.1007/s12672-016-0280-3.

miR-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting KLF6 and KLF15.

Wang K, Ren Y, Liu Y, Zhang J, He J Oncol Res. 2016; 25(2):277-283.

PMID: 27629257 PMC: 7840800. DOI: 10.3727/096504016X14732514133203.